ArticleTherapeutics and clinical risk management2018

No increased risk of psoriasis in patients receiving androgen deprivation therapy for prostate cancer: a 17-year population-based study.

Jui-Ming Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.